Association between alopecia areata, anxiety, and depression: A systematic review and meta-analysis.
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문📑 인용한 논문 (6) ▾
- The Psychiatric Burden in Alopecia Areata: A Propensity-Matched Cohort Study. Dermatology and therapy · 2026
- Illness Perception, Emotional Distress, and Obsessive-Compulsive Symptomatology in Patient… Behavioral sciences (Basel, Switzerland) · 2026
- Global, regional, and national burden of alopecia areata from 1990 to 2021: An analysis fr… JAAD international · 2026
- Analysis of trichoscopic images using deep neural networks for the diagnosis and activity … Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2026
- Knowledge, attitudes, and practices toward disease management among alopecia areata patien… BMC public health · 2025
- Associations between ionomic profile and metabolic abnormalities in a murine model of sodi… Frontiers in pharmacology · 2025
【연구 목적】 원형 탈모증(alopecia areata, AA) 환자에서 불안(anxiety) 및 우울(depression)과의 연관성을 기존 문헌을 종합해 정량적으로 분석하고자 한 첫 메타분석 연구입니다.
- 연구 설계 meta-analysis
Abstract 한글 요약
[OBJECTIVE] We sought to analyze the existing literature to examine the association between alopecia areata, anxiety, and depression.
[METHODS] We extracted literature from 4 databases including MEDLINE, Embase, PsychINFO, and Web of Science. We used the Preferred Reporting Items for Systematic Reviews and Meta-analyses (ie, PRISMA) reporting guidelines to finalize a list of relevant articles to be included in our systematic review and meta-analysis. There were no restrictions placed on publication year or age of participants.
[RESULTS] Eight studies that included 6010 patients with AA and 20 961 control individuals were included in the quantitative analysis. These included 4 cross-sectional studies and 4 case-control studies. Analysis of these studies showed a positive association with anxiety (pooled odds ratio, 2.50; 95% confidence interval, 1.54-4.06) and depression (pooled odds ratio, 2.71; 95% confidence interval, 1.52-4.82).
[LIMITATIONS] Publication bias may be a limitation of the study.
[CONCLUSION] This study suggests that patients with AA are at higher risk of both anxiety and depression. Health care professionals must be cognizant of this higher risk and consider routine assessment of these conditions and referral to appropriate providers when indicated.
추출된 의학 개체 (NER)
전체 NER 표 보기
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 질환 | alopecia areata
|
원형 탈모증 | dict | 3 |
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
인용 관계
이 논문을 인용한 후속 연구 20
- Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients.
- Alopecia Areata: An Updated Review for 2023.
- Epidemiological Trends in Alopecia Areata at the Global, Regional, and National Levels.
- Novel potential therapeutic targets of alopecia areata.
- Anxiety, depression, and quality of life in children and adults with alopecia areata: A systematic r…
- Physician- and Patient-Reported Severity and Quality of Life Impact of Alopecia Areata: Results from…
- Olumniant (Baricitinib) oral tablets: An insight into FDA-approved systemic treatment for Alopecia A…
- Health-related quality of life in patients with alopecia areata: Results of a Japanese survey with n…
- Patient characteristics and disease burden of alopecia areata in the Danish Skin Cohort.
- Patient and physician perspectives on alopecia areata: A real-world assessment of severity and burde…
- Association of mental health outcomes and lower patient satisfaction among adults with alopecia: A c…
- Economic Burden and Healthcare Resource Use of Alopecia Areata in an Insured Population in the USA.
- Advanced Medical Therapies in the Management of Non-Scarring Alopecia: Areata and Androgenic Alopeci…
- Sleep disturbance in alopecia areata: A cross-sectional study.
- The Impact of Sleep Quality on Mood Status and Quality of Life in Patients with Alopecia Areata: A C…
- Safety and Efficacy of Ritlecitinib and Brepocitinib in Alopecia Areata: Results from the Crossover …
- Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLE…
- Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata.
- Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of …
- Treatment Patterns and Unmet Needs in the Management of Alopecia Areata: Results of a Physician's Su…
같은 제1저자의 인용 많은 논문 (4)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- 피나스테리드가 전립선암 발생에 미치는 영향.
- COVID-19의 50가지 이상의 장기 후유증: 체계적 문헌고찰 및 메타분석.
- 양성 전립선 비대증의 임상적 진행에 대한 doxazosin, finasteride 및 병용 요법의 장기 효과.
- 양성 전립선 비대증 환자에서 finasteride의 효과. The Finasteride Study Group.
- 양성 전립선 비대증 남성에서 급성 요폐의 위험과 수술적 치료 필요성에 대한 finasteride의 효과. Finasteride Long-Term Efficacy and Safety Study Group.
- 원형 탈모.
📖 비슷한 OA 논문 — 같은 카테고리, 무료 전문 가능
-
Alopecia areata.
TL;DRAlopecia areata is difficult to manage medically, but recent advances in understanding the molecular mechanisms have revealed new treatments and the possibility of remission in the…
-
Epidemiology and burden of alopecia areata: a systematic review.
TL;DRAA is the most prevalent autoimmune disorder and the second most prevalent hair loss disorder after androgenetic alopecia, and the lifetime risk in the global population is approxi…
-
Two Phase 3 Trials of Baricitinib for Alopecia Areata.
TL;DRIn two phase 3 trials involving patients with severe alopecia areata, oral baricitinib was superior to placebo with respect to hair regrowth at 36 weeks.
-
Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.
TL;DRAlthough a variety of medical, surgical, light‐based and nutraceutical treatment options are available to slow or reverse the progression of AGA, it can be challenging to select ap…
-
Alopecia areata: A multifactorial autoimmune condition.
TL;DRVarious genetic and environmental factors that cause autoimmunity are discussed and the immune mechanisms that lead to hair loss in alopecia areata patients are described.